According to Puni Testing's WeChat account, recently, Puni Biomedical and the Shanghai Institute of Pharmaceutical Sciences of the Chinese Academy of Sciences jointly launched a D3CARP target prediction and virtual screening project. The introduction of artificial intelligence technology in drug screening can greatly improve the operational efficiency of the entire drug development process, assist pharmaceutical companies to develop higher quality drugs, and further enhance the competitive advantage of pharmaceutical companies in the industry.
谱尼生物医药联合中国科学院上海药物研究所推出人工智能靶标预测及虚拟筛选项目
Penney Biomedicine and Shanghai Pharmaceutical Research Institute of the Chinese Academy of Sciences launch artificial intelligence target prediction and virtual screening project
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.